Bristol-Myers Squibb
BMY
BMY
1,520 hedge funds and large institutions have $78B invested in Bristol-Myers Squibb in 2016 Q1 according to their latest regulatory filings, with 93 funds opening new positions, 585 increasing their positions, 604 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
3% less repeat investments, than reductions
Existing positions increased: 585 | Existing positions reduced: 604
12% less capital invested
Capital invested by funds: $88.6B → $78B (-$10.6B)
19% less funds holding in top 10
Funds holding in top 10: 97 → 79 (-18)
Holders
1,520
Holding in Top 10
79
Calls
$680M
Puts
$512M
Top Buyers
| 1 | +$1.05B | |
| 2 | +$533M | |
| 3 | +$318M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$170M |
| 5 |
SG Americas Securities
New York
|
+$125M |
Top Sellers
| 1 | -$511M | |
| 2 | -$277M | |
| 3 | -$182M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$159M |
| 5 |
SAC
Smith Affiliated Capital
New York
|
-$159M |